Skip to content

Healthcare Data News

News from the healthcare data industry

  • Submit News
  • Home
  • Industry News
  • Competitor News
  • Partner and Collaborator News
Healthcare Data News
  • Home
  • Industry News
  • Competitor News
  • Partner and Collaborator News
  • Submit News

Tag: TriNetX

Posted on May 1, 2022May 2, 2022 Collaborations Competitor News Data Partnership

Disparities Observed in Diabetic Retinopathy Rates By Gender, Ethnicity

New findings suggest an increase in odds of diabetic retinopathy (DR) in Black individuals with type 2 diabetes compared to white individuals, while Black women saw an increase in all types of...

Posted on April 29, 2022 Collaborations Competitor News Data Partnership International Middle East RWE Study

Development and Experience with Cancer Risk Prediction Models Using Federated Databases and Electronic Health Records

ABSTRACT Early diagnosis is critical to improving survival rates of lethal cancers, such as pancreatic duct adenocarcinoma (PDAC). However, there are no reliable screening test for these cancers. In this...

Posted on April 20, 2022April 21, 2022 Collaborations Competitor News COVID-19 Data Partnership RWE Study

Tonix Pharmaceuticals Announces Results of Retrospective Observational Database Study In Over 50,000 Long COVID Patients

April 20, 2022 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp. Over 40% of Long COVID Patients Had Fibromyalgia-Like Multi-Site Pain Symptoms Rate of Opioid Use in Long COVID Patients with Multi-Site...

Posted on April 4, 2022 Collaborations Competitor News COVID-19 Data Partnership RWE Study

Blood Cancer Journal Study Finds Multiple Myeloma Patients at Higher Risk of COVID-19 Infection and Mortality

Cambridge, MA, April 4, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Universitario 12 de Octubre...

Posted on March 28, 2022March 28, 2022 Collaborations Competitor News International Japan Product Updates

Mitsui Signs Partnership Agreement with TriNetX to Expand its Global Research Network in Japan

March 28, 2022 – Mitsui & Co., Ltd. (“Mitsui”, Head Office: Tokyo, President and CEO: Kenichi Hori) and TriNetX, LLC (“TriNetX”, Head Office: Massachusetts, U.S., CEO: Gadi Lachman), the global network...

Posted on March 7, 2022March 11, 2022 Collaborations Competitor News Data Partnership

Racial disparities in outcomes of arthroscopic rotator cuff repair: A propensity score matched analysis using multiple national data sets

ABSTRACT BACKGROUND: Disparities in access, utilization and outcomes exist throughout the healthcare system for minority groups, including racial and ethnic minorities; these disparities have wide-reaching implications for individuals as well...

Posted on March 1, 2022March 7, 2022 Collaborations Competitor News Data Partnership

PSA Testing in Men Receiving Testosterone Therapy with History of Prostate Cancer: A Matched Analysis of a Large Multi-Institutional Research Network

Abstract Objective: To investigate the frequency of PSA testing in men receiving TT and with a history of PCa. Methods: We queried the TriNetX network database, a global health research network consisting...

Posted on January 27, 2022 Competitor News HR International Japan

TriNetX Announces the Appointment of Shogo Wakabayashi as Japan Country Manager

Cambridge, MA, January 27, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Shogo Wakabayashi has joined the...

Posted on January 21, 2022January 25, 2022 Competitor News M&A

TriNetX Acquires Pharmacovigilance Leader Advera Health Analytics

CAMBRIDGE, Mass., Jan. 21, 2022 /PRNewswire/ — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the acquisition of Advera Health Analytics,...

Posted on January 13, 2022 Collaborations Competitor News Data Partnership Oncology

Skin-related side effects indicate better prognosis for patients taking certain cancer drugs

Immune checkpoint inhibitors, which strengthen the immune response against tumor cells, have become standard of care for many patients with advanced cancers; however, the medications can often cause side effects,...

Posts pagination

← 1 2 3 4 5 →

  • Search by Keyword

  • Reset Filter
  • Search by Category

  • Search by Company and Location

© 2025 Healthcare Data News / Powered by WordPress / Theme by Design Lab